Novel Antidotes for Target Specific Oral Anticoagulants

Experimental Hematology and Oncology - United Kingdom
doi 10.1186/s40164-015-0020-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

New Alternative to Antidotes for Novel Oral Anticoagulants and Ticagrelor in the Case of Severe Bleeding

Critical Care
Critical CareIntensive Care Medicine
2020English

Novel Oral Anticoagulants for Acute Coronary Syndrome

Therapeutic Advances in Cardiovascular Disease
Cardiovascular MedicinePharmacologyCardiology
2016English

Novel Oral Anticoagulants and Risk

Clinical Oral Implants Research
Oral Surgery
2018English

Evidence of Novel Oral Anticoagulants (NOAC)

Clinical Neurology
Neurology
2013English

The Hope for Novel Oral Anticoagulants and Related Problems

Folia Pharmacologica Japonica
Pharmacology
2014English

Pharmacovigilance for Novel Oral Anticoagulants: Why Is It So Crucial?

Journal of Pharmacovigilance
2015English

Introduction to Direct Oral Anticoagulants and Rationale for Specific Reversal Agents

American Journal of Emergency Medicine
MedicineEmergency Medicine
2016English

Novel Oral Anticoagulants, a Subject in Continuing Debate

Internal Medicine
2018English

The Use of Novel Oral Anticoagulants in Atrial Fibrillation

Cardiovascular and Hematological Disorders - Drug Targets
Molecular MedicinePharmacologyCardiologyHematologyCardiovascular MedicineMedicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy